TELA Bio (TELA) Return on Capital Employed Growth (5y) (2024 - 2026)
TELA Bio (TELA) Return on Capital Employed Growth (5y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | TELA Bio | 38.25 Mn | -1.29 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,454.00 |
| Dec 31, 2025 | -3,254.00 |
| Sep 30, 2025 | -4,734.00 |
| Jun 30, 2025 | -4,126.00 |
| Mar 31, 2025 | -2,619.00 |
| Dec 31, 2024 | -1,353.00 |
| Sep 30, 2024 | 20,730.00 |